对药品行业来说,今年是非常关键的一年。一方面政府对于如何改革国家的医疗体制——通过私营机构间的竞争还是增加公共卫生服务——将会明朗,而最终的决定对医药行业内各大机构及企业将会有深远的影响。另一方面,国家食品药品监督管理局也会落实之前公布的《药品说明书和标签管理规定》(国家食品药品监督管理局24号),以下简称24号令。24号 This year is a very crucial year for the pharmaceutical industry. On the one hand, it will be clear to the government how to reform the country’s medical system - through private-sector competition or increase in public health services. The final decision will have far-reaching implications for the major institutions and enterprises in the pharmaceutical industry. On the other hand, the State Food and Drug Administration will also implement the previously promulgated Regulations on the Administration of Drug Specifications and Labels (State Food and Drug Administration No. 24), hereinafter referred to as Order No. 24. 24th